跳至主要内容
临床试验/NL-OMON36554
NL-OMON36554
已完成
不适用

Clinical Application of a Dermal Substitute based on glycerol preserved Allograft: GLYADERM® A multicentre, prospective, controlled, randomized, comparative trial of Glyaderm® and split thickness skin graft versus split thickness skin graft alone in full thickness skin defects - Multicentre evaluation Glyaderm®

Euro Tissue Bank0 个研究点目标入组 2 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
burn wounds
发起方
Euro Tissue Bank
入组人数
2
状态
已完成
最后更新
去年

概览

简要总结

Trial is onging in other countries

注册库
who.int
开始日期
待定
结束日期
2014年5月15日
最后更新
去年
研究类型
Interventional

研究者

发起方
Euro Tissue Bank

入排标准

入选标准

  • All clearly full thickness burns or skin defects (TBSA Full Thickness Burn \< 30%) as clinically evaluated by two plastic surgeons and/or specialist burn surgeons
  • Possibility to follow the complete treatment schedule until final graft take and subsequently wound healing and finally participation in the follow\-up schedule
  • Informed consent has been obtained

排除标准

  • All partial thickness burns that can heal by conservative treatment
  • Patients younger than 18 years of age
  • TBSA \> 30 %
  • Study wound smaller than 100 cm² or greater than 800cm2\.
  • No follow\-up till wound closure or withdrawal before start of follow\-up
  • Patient has any condition(s) that seriously compromises the patient\*s ability to complete this study
  • Patient has participated in another study utilizing an investigational drug within the previous 30 days
  • Patient has one or more medical condition(s), diabetes, including renal, hepatic, hematologic, neurologic, or immune disease that in the opinion of the investigator would make the patient an inappropriate candidate for this study

结局指标

主要结局

未指定

相似试验